HomeSCPI • IDX
add
Organon Pharma Indonesia Tbk PT
Market news
Financials
Income Statement
Revenue
Net income
| (IDR) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 886.31B | 27.92% |
Operating expense | 13.57B | 2.29% |
Net income | 81.25B | 71.01% |
Net profit margin | 9.17 | 33.67% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | 23.29% | — |
Balance Sheet
Total assets
Total liabilities
| (IDR) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 158.23B | -19.92% |
Total assets | 1.92T | 18.15% |
Total liabilities | 810.02B | 9.36% |
Total equity | 1.11T | — |
Shares outstanding | 3.60B | — |
Price to book | 93.69 | — |
Return on assets | 14.51% | — |
Return on capital | 23.99% | — |
Cash Flow
Net change in cash
| (IDR) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 81.25B | 71.01% |
Cash from operations | 46.68B | -53.43% |
Cash from investing | -1.87B | 91.53% |
Cash from financing | -766.16M | 79.27% |
Net change in cash | 44.04B | -40.84% |
Free cash flow | 11.66B | -81.58% |
About
Founded
1972
Website
Employees
179
